ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 400245 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 400245; 2) Community: the network communities that were significantly associated with the response to NSC 400245; 3) Molecule: the relationships between components within communities and NSC 400245; 4) MDR: the compounds that were significantly associated with the NSC 400245.

NSC Compound Enrichment Correlation
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0490935610249072 0.53321468
NSC 241494 Null 1.92684808686038e-005 0.65020003
NSC 703329 Null 1.9268480868604e-005 0.50447787
NSC 234214 NSC 234214 2.60114781708975e-005 0.60395232
NSC 679108 Phenol, 4,4'-(5,5'-biisoxazole-3,3'-diyl)bis- 4.91939766674006e-005 0.3212987
NSC 623989 Null 5.49145982993963e-005 0.63708136
NSC 625543 ANTINEOPLASTIC-625543 5.49145982993963e-005 0.34637418
NSC 701109 Null 8.12512419150697e-005 -0.26800988
NSC 740362 Null 8.12512419150697e-005 0.46678748
NSC 754824 4-[4-(3-Methoxy-phenyl)-piperazin-1 -yl]-5H-pyrrolo[3,2-d]pyrimidine 8.12512419150697e-005 0.40659953
Total:81  Current:80    [First] [Prev] [Next] [Last]